We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genes Found That Extend Lifespan

By Biotechdaily staff writers
Posted on 13 Oct 2005
Scientists have found new genes associated with lifespan extension in yeast. More...


Significantly reducing calorie intake, or caloric restriction, is known to extend the lifespan of organisms including yeast, worms, and rodents. Earlier studies tied a gene called Sir2 with lifespan extension caused by caloric restriction, but yeast and worms that lack Sir2 also live longer when put on a restricted diet, demonstrating that some other genes must be at work.

Researchers led by Dr. David Sinclair at Harvard Medical School (Boston, MA, USA) and Dr. Su-Ju Lin from the University of California, Davis, Center for Genetics and Development and Section of Microbiology (UC Davis; USA) screened for other life-extending genes in yeast. They discovered a gene called Hst2 that accounts for most of the discrepancy.

Deleting Hst2 and Sir2 blocked most of the beneficial effect of caloric restriction. When Hst2 was overexpressed, so that the gene was more active than normal, the yeast lived longer than normal. A third gene, Hst1, seems to function when both Sir2 and Hst2 are missing. Sir2 and the newly found Hst genes account for all of the life-extending effects of caloric restriction in yeast, according to Dr. Lin.

In yeast, the effects of aging seem to be caused by an accumulation of toxic circular DNA molecules that mistakenly get copied out of ribosomal DNA, an unstable region of the yeast genome that contains hundreds of repeated sequences. The investigators showed that caloric restriction dramatically reduces recombination of ribosomal DNA, and that deleting Hst2 and Sir2 stops this process.

Very similar genes are found in broadly diverse animals including worms, flies, and rodents. However, the targets of these genes are likely to be different, as the toxic DNA circles have not been identified in more sophisticated organisms, according to Dr. Lin.

The study was published in the September 16, 2005, issue of the journal Science.






Related Links:
Harvard Medical School
University of California, Davis

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.